Not necessarily that all pharma companies are changing their business model this frequently.
I hold two other pharma companies :
- India centric Abbott India ltd…This company sells medicines in India. Its leader in many categories and its business model is quite robust as well as constant.
- API low cost producer Divis Labs…This company also has proven and profitable business model. Due to sudden opportunity lost of covid drug, this stock has also come down more than 35%, but its business model is intact and not much difference…Its on track…
So not all companies in Pharma sector are changing their business model so frequently like Laurus.
Subscribe To Our Free Newsletter |